Benign paroxysmal positional vertigo medical therapy

Jump to navigation Jump to search

Benign paroxysmal positional vertigo Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Benign Paroxysmal Positional Vertigo from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Benign paroxysmal positional vertigo medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Benign paroxysmal positional vertigo medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Benign paroxysmal positional vertigo medical therapy

CDC on Benign paroxysmal positional vertigo medical therapy

Benign paroxysmal positional vertigo medical therapy in the news

Blogs on Benign paroxysmal positional vertigo medical therapy

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Benign paroxysmal positional vertigo medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Pharmacologic medical therapy is recommended among BPPV patients who does not answer well to Epley maneuver and continue to have multiple vertigo attacks which reduces their quality of life. Preferred regimen Betahistine 24 mg PO q12h for 7 days.

Medical Therapy

Benign paroxysmal positional vertigo

  • Preferred regimen : Betahistine 24 mg PO q12h for 7 days

References

  1. Cavaliere M, Mottola G, Iemma M (April 2005). "Benign paroxysmal positional vertigo: a study of two manoeuvres with and without betahistine". Acta Otorhinolaryngol Ital. 25 (2): 107–12. PMC 2639876. PMID 16116833.

Template:WH Template:WS